DK157678C - Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden - Google Patents

Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden

Info

Publication number
DK157678C
DK157678C DK303481A DK303481A DK157678C DK 157678 C DK157678 C DK 157678C DK 303481 A DK303481 A DK 303481A DK 303481 A DK303481 A DK 303481A DK 157678 C DK157678 C DK 157678C
Authority
DK
Denmark
Prior art keywords
sup
sub
group
acceptable salts
therapeutically acceptable
Prior art date
Application number
DK303481A
Other languages
English (en)
Other versions
DK157678B (da
DK303481A (da
Inventor
Otto Agne Torsten Olsson
Leif Aake Svensson
Kjell Ingvar Leopold Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of DK303481A publication Critical patent/DK303481A/da
Publication of DK157678B publication Critical patent/DK157678B/da
Application granted granted Critical
Publication of DK157678C publication Critical patent/DK157678C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/34—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton and at least one hydroxy group bound to another carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Luminescent Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK303481A 1980-07-09 1981-07-08 Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden DK157678C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8022439 1980-07-09
GB8022439 1980-07-09
GB8116441 1981-05-29
GB8116441 1981-05-29

Publications (3)

Publication Number Publication Date
DK303481A DK303481A (da) 1982-01-10
DK157678B DK157678B (da) 1990-02-05
DK157678C true DK157678C (da) 1990-06-18

Family

ID=26276161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK303481A DK157678C (da) 1980-07-09 1981-07-08 Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden

Country Status (29)

Country Link
US (2) US4419364A (da)
EP (1) EP0043807B1 (da)
KR (3) KR850000301B1 (da)
AT (1) ATE7689T1 (da)
AU (1) AU539976B2 (da)
CA (1) CA1180021A (da)
CS (1) CS221845B2 (da)
CY (1) CY1273A (da)
DD (1) DD202001A5 (da)
DE (1) DE3163871D1 (da)
DK (1) DK157678C (da)
ES (3) ES503768A0 (da)
FI (1) FI73666C (da)
GR (1) GR74291B (da)
HK (1) HK5385A (da)
HU (2) HU184959B (da)
IE (1) IE51373B1 (da)
IS (1) IS1262B6 (da)
LU (1) LU88304I2 (da)
MX (1) MX9203239A (da)
MY (1) MY8700026A (da)
NO (2) NO152130C (da)
NZ (1) NZ197628A (da)
PH (2) PH16535A (da)
PL (1) PL128513B1 (da)
PT (1) PT73336B (da)
SG (1) SG79784G (da)
SU (1) SU1128830A3 (da)
YU (3) YU42116B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904064D0 (sv) * 1989-12-01 1989-12-01 Astra Ab Improved method of preparing an intermediate for the manufacture of bambuterol
SE9000948D0 (sv) 1990-03-16 1990-03-16 Draco Ab New use
US5830422A (en) * 1995-06-23 1998-11-03 Ormiston Mining And Smelting Co. Ltd. Method for production of sodium bicarbonate, sodium carbonate and ammonium sulfate from sodium sulfate
CA2247953A1 (en) * 1996-01-29 1997-07-31 E. Charles Pesterfield Jr. Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
KR20030085658A (ko) * 2002-04-30 2003-11-07 한올제약주식회사 밤부테롤의 개선된 합성방법
US7495028B2 (en) * 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
CN100356913C (zh) * 2002-08-08 2007-12-26 谭文 左旋(r)班布特罗及其药物用途
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
NZ574905A (en) 2006-08-22 2011-12-22 Ranbaxy Lab Ltd Matrix metalloproteinase inhibitors
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
KR20130042590A (ko) 2010-07-30 2013-04-26 랜박시 래보러터리스 리미티드 기질 메탈로프로테나제 저해제
EA201390404A1 (ru) 2010-09-24 2013-09-30 Ранбакси Лабораториз Лимитед Ингибиторы матричной металлопротеиназы
DK2925725T3 (da) 2012-12-03 2017-01-16 Pfizer Androgenreceptormodulatorer
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN104557614B (zh) * 2014-12-15 2017-01-04 广东东阳光药业有限公司 一种胺的还原方法
CN105622461B (zh) * 2016-01-29 2018-06-19 华南理工大学 一种化合物及其制备方法与应用
CN105859589B (zh) * 2016-04-05 2018-09-28 深圳市康立生生物科技有限公司 一种制备班布特罗杂质c的方法
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
CN109942462B (zh) * 2019-03-06 2022-01-14 宏冠生物药业有限公司 一种盐酸班布特罗的合成工艺
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE178032C1 (da) 1961-01-01
DE1643488U (de) 1949-11-28 1952-09-11 G E Hilge Fa Brutgeraet.
DK85789C (da) 1955-07-05 1958-06-30 Cilag Ag Fremgangsmåde til fremstilling af d,1- eller 1-isopropyl-aminometyl-(3,4-dihydroksy-fenyl)-karbinol eller salte deraf.
DE1768167U (de) 1958-04-02 1958-06-04 Artur O Herrmann Warngeraet bei strassenhindernissen.
DE1275069B (de) 1960-02-15 1968-08-14 Boehringer Sohn Ingelheim 1-(3', 5'-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoalkane und Verfahren zu ihrer Herstellung
BE622434A (da) 1961-09-14
FR1324857A (fr) * 1962-06-14 1963-04-19 Chemie Linz Ag Procédé pour la préparation de dérivés de la phényléthanolamine
GB1141606A (en) 1965-04-12 1969-01-29 Rech S Et D Applic Scient Et M Improvements in alkyl ethers of substituted phenylaminoethanols
DE1543372A1 (de) 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen
SE358633B (da) 1966-10-19 1973-08-06 Draco Ab
US3937838A (en) * 1966-10-19 1976-02-10 Aktiebolaget Draco Orally active bronchospasmolytic compounds and their preparation
NO132866C (da) 1966-10-19 1976-01-21 Draco Ab
SE335359B (da) 1966-10-19 1971-05-24 Draco Ab
FR6087M (da) 1967-01-10 1968-06-04
SE369299B (da) 1967-10-18 1974-08-19 Draco Ab
SE338324B (da) 1967-12-19 1971-09-06 Haessle Ab
GB1298771A (en) 1969-04-01 1972-12-06 Sterling Drug Inc Carboxylic esters of hydroxyphenylalkanolamines
AT294046B (de) 1969-07-08 1971-11-10 Chemie Linz Ag Verfahren zur Herstellung des N,N'-Bis[2-(3',4'-dihydroxyphenyl)-2-hydroxyäthyl]-hexamethylendiamins, seiner optisch aktiven Formen und der Salze derselben
US3657319A (en) * 1970-05-05 1972-04-18 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols
NO126437B (da) 1970-08-05 1973-02-05 Draco Ab
NL7112938A (da) 1970-09-30 1972-04-05
CH550771A (de) 1970-10-30 1974-06-28 Hoffmann La Roche Verfahren zur herstellung von phenaethylaminderivaten.
US3876679A (en) 1970-12-09 1975-04-08 Aldrich Chem Co Inc Di-substituted phenethylcarbamic acid esters
FI55988C (fi) 1971-10-19 1979-11-12 Klinge Co Chem Pharm Fab Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
US4011258A (en) 1973-06-21 1977-03-08 Aktiebolaget Draco Orally active bronchospasmolytic compounds
FI56673C (fi) 1974-03-29 1981-02-04 Huhtamaeki Yhthymae Oy Nytt foerfarande foer framstaellning av alfa-tert-bytylaminometyl-4-hydroxy-m-xylen-alfa1 alfa3-diol
JPS556625B2 (da) 1974-05-16 1980-02-18
US4063025A (en) * 1975-02-05 1977-12-13 Yamanouchi Pharmaceutical Co., Ltd. 4-Substituted amino-α-aminomethylbenzyl alcohol derivatives
SE7510988L (sv) 1975-10-01 1977-04-02 Draco Ab Nya farmaceutiskt aktiva foreningar
DE2710997C3 (de) * 1977-03-14 1980-08-14 Dr. Karl Thomae Gmbh, 7950 Biberach 4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
YU43169B (en) 1989-04-30
ES513109A0 (es) 1983-03-01
IS2657A7 (is) 1982-01-10
KR850000870B1 (ko) 1985-06-22
SG79784G (en) 1985-04-26
CA1180021A (en) 1984-12-27
US4419364A (en) 1983-12-06
PT73336B (en) 1983-09-01
KR850000301B1 (ko) 1985-03-18
CS221845B2 (en) 1983-04-29
GR74291B (da) 1984-06-21
DK157678B (da) 1990-02-05
FI73666B (fi) 1987-07-31
ES8300678A1 (es) 1982-11-01
LU88304I2 (fr) 1994-05-04
DD202001A5 (de) 1983-08-24
FI812158L (fi) 1982-01-10
NO152130B (no) 1985-04-29
NO812311L (no) 1982-01-11
HK5385A (en) 1985-01-25
EP0043807B1 (en) 1984-05-30
PL128513B1 (en) 1984-02-29
NO1996008I1 (no) 1996-06-27
HU187611B (en) 1986-02-28
KR830006174A (ko) 1983-09-20
ES503768A0 (es) 1982-11-01
YU86483A (en) 1983-12-31
IE811522L (en) 1982-01-09
HU184959B (en) 1984-11-28
KR850002740A (ko) 1985-05-15
AU7261881A (en) 1982-01-14
IS1262B6 (is) 1987-03-27
YU170481A (en) 1983-12-31
ES8304072A1 (es) 1983-02-16
KR850002741A (ko) 1985-05-15
AU539976B2 (en) 1984-10-25
CY1273A (en) 1985-03-08
EP0043807A3 (en) 1982-09-22
PH16535A (en) 1983-11-10
SU1128830A3 (ru) 1984-12-07
FI73666C (fi) 1987-11-09
YU42116B (en) 1988-04-30
YU86383A (en) 1983-12-31
ATE7689T1 (de) 1984-06-15
US4451663A (en) 1984-05-29
MY8700026A (en) 1987-12-31
YU43168B (en) 1989-04-30
IE51373B1 (en) 1986-12-10
KR850000871B1 (ko) 1985-06-22
EP0043807A2 (en) 1982-01-13
PT73336A (en) 1981-08-01
PL232108A1 (da) 1982-08-02
NO152130C (no) 1985-08-07
DK303481A (da) 1982-01-10
MX9203239A (es) 1992-07-01
NZ197628A (en) 1985-07-12
ES513108A0 (es) 1983-02-16
DE3163871D1 (en) 1984-07-05
ES8304534A1 (es) 1983-03-01
PH19447A (en) 1986-04-18

Similar Documents

Publication Publication Date Title
DK157678C (da) Analogifremgangsmaade til fremstilling af amider af hydroxyfenylalkylaminoaetanoler eller terapeutisk acceptable salte deraf samt acetofenonderivat til anvendelse som udgangsmateriale ved fremgangsmaaden
ES2053524T3 (es) Un procedimiento para preparar un compuesto quimico.
DK163120C (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf
MX4767E (es) Procedimiento para la preparacion de derivados del 1,8-etano-5-oxo octa y decahidroquinolinas
DK150541C (da) Analogifremgangsmaade til fremstilling af 1-(3-bromisoxazol-5-yl)-2-tert.-butyl-aminoethanol eller farmaceutisk acceptable syreadditionssalte heraf
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
ATE25661T1 (de) Aphidicolanderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
JPS5219684A (en) Preparation of novel alpha-amino acid derivatives
FI824061A0 (fi) Foerfarande foer framstaellning av nya 3'''-dehydro-kardenolid-tridigitoxosidoximer och anvaendning dem som laekemedel